New Mexico recalls

PS Seasoning & Spices non-fat dry milk was made with milk powder that a supplier recalled due to Salmonella contamination. The affected product is 1 lb packages with lot number 2025-45065 and expiration date 06/06/2027. About 264 lbs were distributed nationwide.

PS Seasoning & Spices produced a food binding product using milk powder that was contaminated with Salmonella. The contamination was identified by the milk powder supplier and led to this recall. The affected product is a 50-pound commercial ingredient sold under the Save A Lot Bind name.

Blackstone Parmesan Ranch Seasoning was made with milk powder that a supplier recalled due to Salmonella contamination. The affected seasoning was distributed nationwide. No illnesses have been reported.

PS Seasoning & Spices recalled a jalapeno heat unit seasoning (Part #180002945, 18 lbs) because it was made with milk powder that a supplier recalled due to Salmonella contamination. The affected product has lot #2025-44769 with expiration date 05/27/2027.

PS Seasoning & Spices' 1P Original Smokehouse Unit seasoning mix (Part #180002964, Lot #2025-44770) was made with milk powder that a supplier recalled due to Salmonella contamination. The affected product is a 15.10 lb bulk seasoning designed for smoking meat.

PS Seasoning & Spices recalled Ellsworth Sour Cream + Onion Seasoning because it was made with milk powder that was contaminated with Salmonella. The affected product is a bulk seasoning (25-lb bags) distributed nationwide. Lot #2026-51127 is included in this recall.

Wellnov Supplements LLC's Liposomal Sleep Spray was manufactured without proper safety controls, creating the potential for bacterial contamination and botulism. The affected product was distributed nationwide and in Puerto Rico between October 2025 and April 2026.

Wellnov Liposomal B12 Spray was manufactured with deviations from safety standards that could allow bacterial pathogens, including botulism-causing bacteria, to contaminate the product. The affected bottles were distributed nationwide and to Puerto Rico between October 2024 and April 2026.

Wellnov Supplements LLC is recalling Liposomal D3+B12 Spray due to manufacturing process deviations that could allow bacterial pathogens, including C. botulinum, to contaminate the product. The affected spray (lot DB1024, expiration 10/2026) was distributed nationwide and in Puerto Rico between October 2024 and April 2026.

Wellnov Supplements LLC recalled its Liposomal D3-5000IU Spray due to manufacturing process deviations that could allow bacterial contamination, including potential botulism-causing bacteria. The affected product is a 30 ml aluminum bottle spray (lot DS1024, expiration 10/2026) distributed nationwide between October 2024 and April 2026.

Wellnov Supplements LLC is recalling Liposomal Prenatal+Postnatal Liquid Multivitamin Drops (Iron Free) due to manufacturing deviations that could allow bacterial pathogens, including C. botulinum, to contaminate the product. The affected bottles were distributed nationwide between September 2024 and April 2026.

Wellnov Supplements LLC is recalling Liposomal Women's Liquid Multivitamin Drops (Iron Free) due to manufacturing issues that could allow bacterial growth, including a potential risk of botulism. The product was distributed nationwide and in Puerto Rico between October 2024 and April 2026.

Wellnov Supplements LLC is recalling Liposomal Kids Liquid Multivitamin Drops due to manufacturing defects that could allow harmful bacteria, including C. botulinum, to contaminate the product. The affected bottles were distributed nationwide and in Puerto Rico between June 2025 and April 2026.

Wellnov Supplements LLC is recalling Liposomal Collagen Booster liquid supplement due to manufacturing process deviations that could allow bacterial contamination, including the risk of C. botulinum. The product was distributed nationwide and in Puerto Rico between June 2025 and April 2026.

Wellnov Supplements LLC is recalling Liposomal Women's Liquid Multivitamin Drops with Iron due to manufacturing process deviations that could allow bacterial contamination, including potential botulism risk. The affected product was distributed nationwide between June 2025 and April 2026.

Wellnov Supplements LLC recalled Liposomal Mens 50+ Liquid Multivitamin Drops due to manufacturing issues that could allow harmful bacteria, including botulism-causing organisms, to contaminate the product. The 90 mL bottles were distributed nationwide and in Puerto Rico between June 2025 and April 2026.

Wellnov Supplements' Liposomal Mens Liquid Multivitamin Drops may contain harmful bacteria, including potential C. botulinum, due to manufacturing practice violations. The product was distributed nationwide and in Puerto Rico between October 2024 and April 2026. No injuries have been reported.

Wellnov Supplements LLC is recalling Liposomal Womens 50+ Liquid Multivitamin Drops due to manufacturing deviations that could allow bacterial growth, including a possible risk of Clostridium botulinum contamination. The affected bottles were distributed nationwide and in Puerto Rico between October 2024 and April 2026.

Wellnov Supplements' FulviLife Complex liquid supplement failed to meet manufacturing safety standards, which could allow harmful bacteria including botulism to grow in the product. The affected bottles were distributed nationwide and to Puerto Rico between October 2024 and April 2026.

Wellnov Supplements Joint Nourish liquid supplement was manufactured with deviations from required safety standards that could allow harmful bacteria, including those that cause botulism, to contaminate the product. About 90 bottles distributed nationwide between October 2025 and April 2026 may be affected.

Wisconsin Pharmacal Company's MG217 Multi-Symptom Treatment Cream (colloidal oatmeal 2%, 6 oz) has been found to contain Staphylococcus aureus bacteria. The contamination was confirmed in lot #1024088 (expiration 11/30/2026). About 690 tubes were distributed nationwide and to the Bahamas.

IntegraDose Compounding Services LLC has recalled fentanyl citrate sterile injection (2,250 mcg/50 mL) because the drug may contain less active ingredient than labeled. This lot was distributed nationwide to healthcare facilities.

UCB Biosciences is recalling specific lots of Cimzia (certolizumab pegol) 200 mg prefilled syringes because the manufacturer cannot confirm the product remained sterile during production. This is a precautionary recall; no infections or injuries have been reported so far.

Zydus Pharmaceuticals is recalling erythromycin 500 mg tablets because testing found a chemical impurity (N-Nitroso-Desmethyl-Erythromycin) at levels higher than FDA's recommended safe intake limit. The impurity resulted from manufacturing process deviations at the maker in India. No injuries have been reported.

Zydus Pharmaceuticals is recalling erythromycin tablets (250 mg) due to the presence of N-Nitroso-Desmethyl-Erythromycin, a nitrosamine impurity, at levels above the FDA's acceptable intake limit. The affected bottles were distributed nationwide. This impurity can potentially increase cancer risk with long-term exposure.

ANI Pharmaceuticals is recalling estradiol gel (0.1%, 0.25 mg packets) because some packets in affected cartons were found to be empty or only partially filled. This could mean patients receive less medication than prescribed. The recall affects carton lot M251109, which expires in November 2027.

Gas-X Simethicone 125 mg softgels distributed by Haleon are being recalled because the carton labeling does not list all inactive ingredients. This affects three specific lot codes (KB5Y, MP4B, and SS4F) distributed nationwide.

Lupin Pharmaceuticals is recalling certain batches of Liraglutide Injection (a diabetes and weight-loss medication) because white thread-like particles have been found inside the cartridges. The affected pens are distributed nationwide. No injuries have been reported.

Sagent Pharmaceuticals is recalling two lots of Busulfan Injection due to failed impurities and degradation specifications. The affected lots are 656412 (expiring 08/31/2026) and 659646 (expiring 03/31/2027). This is a prescription medication used in cancer treatment.

Amerisource Health Services has recalled certain batches of Primidone Tablets, USP, 50 mg due to cross-contamination during manufacturing. The tablets contain trace amounts of Acemetacin, a different active pharmaceutical ingredient, which should not be present in this medication.